Status of work in February
In February, AOTMiT begins work on orders from the Minister of Health:
- Ozempic (semaglutide) for the treatment of type 2 diabetes
- Lyvdelzi (seladelpar) for the treatment of patients with primary biliary cholangitis (PBC)
- Zilbrysq (zilucoplan) for the treatment of patients with generalized myasthenia gravis
The listed order is available on the AOTMiT Public Information Bulletin.